Delivery Order SPE2DB20D1109-SPE2DB25FP69E
- Not listed
- The Defense Logistics Agency awarded a $3,604.57 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This competitive delivery order, which is set to be completed by September 18, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,089.14. This is a firm fixed-price, non-set-aside contract with performance completion scheduled for September 15, 2025, and fulfillment to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $5,258.71. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,433.92 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units. This contract is a firm fixed price delivery order with no set-aside designation, competitively awarded to the vendor's Corporate Office located in Conshohocken, Pennsylvania. The award was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, indicating a rapid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $1,083.78. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets (1,000 count) at a firm fixed price of $1,094.58. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pantoprazole Sodium Delayed-Release 20 mg tablets (90-count) with a ceiling value of $10,104.38. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, executed without set-aside provisions through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units. This is a firm fixed-price delivery order valued at $1,870.34, with an ultimate completion date of June 20, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.58 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on September 17, 2025, with performance occurring at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a 90-count package. This order, valued at $1,120.33, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The award is non-set-aside and was...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP69EDelivery Order
The Defense Logistics Agency awarded a $1,794.12 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Pantoprazole Sodium delayed-release 40 milligram on September 4, 2025, with completion scheduled for September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing comprehensive medical procurement services to federal health systems, including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, demonstrating significant capability in fulfilling federal medical supply requirements through competitive procurement processes. Pantoprazole sodium is a proton pump inhibitor commonly used in military and veteran healthcare settings for gastrointestinal treatment, representing routine pharmaceutical resupply under the DLA's global pharmaceutical support program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/4/25 |